Please assess the completion status of the following clinical trial:

Trial Title: Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criterion:~* Older individuals who are long-term AIDS survivors and suffer from moderate-to-severe demoralization.~Exclusion Criteria:~* A physical, neurological or cognitive condition that makes participating in the study unsafe or unfeasible.~* Regular psychotropic medication use.~* Personal or family history of serious mental illness.~* Severe depression requiring immediate standard-of-care treatment.~* Exclusion by the clinical judgment of the study investigators.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group therapy plus psilocybin (Type: EXPERIMENTAL): Modified brief Supportive-Expressive Group Therapy will be administered as ten twice-weekly sessions. Oral psilocybin will be administered once in a clinical setting.

Based on this trial design, predict the completion outcome and termination type (if applicable).